In view of the concern regarding the potential risks and (urinary sodium excretion 95 ؎ 36 vs 174 ؎ 40 mmols/24-h, respectively), clinic supine SBP fell by 8 benefits of sodium restriction, the effect on biochemical and orthostatic responses from a moderate reduction in mm Hg (95% CI: 1-15 mm Hg, P Ͻ 0.05) and diastolic BP (DBP) by 1 mm Hg (CI: −3 to 5 mm Hg); there was no sodium intake in elderly persons that is sufficient to lower systolic blood pressure (SBP) was examined. change in total LDL-and HDL-cholesterol and triglyceride levels, serum calcium, phosphate, parathyroid horSeventeen hypertensive subjects aged 65-79 years entered a double-blind randomized placebo controlled mone, glucose, creatinine clearance or urinary albumin excretion rate. Serum urate was significantly higher durcross-over trial of a low sodium diet plus placebo tablets vs a low sodium diet plus sodium tablets (80 ing the low compared to high sodium intake (304 ؎ 56 vs 277 ؎ 44 mols/l). Orthostatic BP responses during mmols/day) each for 5 weeks. At the end of high and low sodium periods, two 24-h urine collections and venous the high and low sodium intakes were unchanged. In summary, after 5 weeks of moderate sodium blood samples were undertaken and supine and standing BPs were recorded. restriction no adverse effects other than an increase in serum urate was seen in elderly hypertensive persons. On the low compared to the high sodium phase
Introduction
to reduce their sodium intake. Concerns have been A reduction in sodium intake has been shown in raised, however, that a reduction in sodium intake many studies to lower blood pressure (BP) in permay have side effects, [16] [17] [18] [19] particularly circulatory sons with hypertension [1] [2] [3] [4] and is advocated as part (eg, orthostatic hypotension 20 ), and metabolic of a non-pharmacological programme for BP adverse effects (eg disturbances of serum lipids and reduction by National and International Committees glucose [21] [22] [23] [24] ). The elderly in particular, by virtue of concerned with hypertension management. [5] [6] [7] The impaired homeostatic mechanisms or concomitant Committee on Medical Aspects of Food Policy also pathology, may be susceptible to such side effects, recommend a population reduction in sodium especially orthostatic hypotention and impaired gluintake to approximately 100 mmols/day. 8 It has been cose tolerance, which increases in prevalence with suggested that the hypotensive effect of a given age. 25 reduction in sodium intake increases with the subThe present study addresses the effects of a modjects age and BP level, making this manoeuvre of erate reduction in sodium intake on certain BP and greater potential value in the elderly hypertensive metabolic parameters in elderly hypertensive subperson. 9 In a recent study we have demonstrated jects. The results of sodium restriction on BP levels that a moderate degree of sodium restriction did sighave previously been published; 10 this report nificantly lower supine systolic BP (SBP) in hyperpresents data on the changes in orthostatic BP tolertensive subjects aged 65-79 years. 10 In addition to ance, blood lipids and other biochemical parameters lowering systemic BP, sodium restriction may also and renal function. have beneficial effects on renal haemodynamics, urinary protein excretion 11, 12 and bone mineralisation.
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Subjects and methods
As the prevalence of hypertension increases markedly with age a large number of elderly subjects Subjects A detailed description of the study design has previously been published. 10 In brief, 17 hypertensive (DBP) у95 mm Hg), of whom two were newly diag-nosed and the remainder had been off antihypertenDefinition of 'responders' to sodium restriction sive treatment for at least 6 weeks, were studied.
The BP response or 'sensitivity' of the group to sodium restriction was considered as a continuous variable and also as a discrete response. Because of Procedures the greater reproducibility of mean 24-h BP After a 4-week pre-run-in period on their usual diet, measurements compared to clinic recordings 26 the all subjects entered a further 4-week run-in period former were used to arbitrarily divide subjects into during which a low sodium diet, aiming to reduce 'responders', those showing a fall in mean 24-h SBP intake to 80-100 mmol/day, was introduced. This у5 mm Hg on the low compared to high sodium was followed by a 10-week double-blind placebo phase or 'non-responders', those with Ͻ5 mm Hg controlled cross-over trial of a 5-week low sodium fall in SBP between phases. diet plus placebo tablets, and a 5-week low sodium diet plus sodium tablets (80 mmols/day) while Statistical analysis remaining on the low dietary sodium intake. Three supine BP measurements and heart rate were
The study had a power of 80% at the 5% signifirecorded after 10 min of rest and then after 1, 2 and cance level to reveal a difference between high and 3 min of standing, 2 weeks into each phase and at low sodium phases in orthostatic SBP of у7 mm Hg, the end of each 5-week phase. One Hawksley ranassuming a standard deviation (s.d.) for repeated dom zero sphygmomanometer was used to take all measurements of 11 mm Hg 27 and in total choles-BP measurements by the same investigator; in terol of у0.4 mmol/l assuming a s.d. of 0.5 mmol/l addition home 24-h ambulatory BP monitoring for repeat measurements. 28 The orthostatic BP (SpaceLabs 90207, WA, USA) was carried out at the change was defined as the mean of three supine BP end of the low and high sodium phases. Venous measurements minus the mean of three standing BP blood samples were taken into EDTA tubes for estimeasurements. For the whole group (n = 17), varimation of plasma renin activity (PRA), aldosterone ables, except urinary albumin excretion rate were and parathyroid hormone (PTH), and into plain approximately normally distributed and results are tubes for lipid and biochemical analysis at the end presented as mean ± s.d. Comparison of these variof each phase at the same time of day and a miniables between phases of the study was by paired tmum of 4 h after food. Immediately after venetests. Correlations between variables was made by puncture, samples were placed on ice and centriPearsons linear correlation coefficient. Non-parafuged for 15 min at 4°C, the supernatant removed metric tests were used to compare albumin and stored at −70°C; samples were then analysed excretion rates, and data are presented as median in batches.
values and inter-quartile ranges. Comparison At the end of the pre-run-in, run-in, low and high between responder and non-responder sub-groups sodium phases, two 24-h urine collections were was by the Mann-Whitney test and intra-group commade from which 10 ml aliquots were frozen for parisons of variables by the Wilcoxson matched determination of albumin excretion rate. Body pairs signed rank test. Multiple linear regression weight in light clothing and height was recorded at analysis using the Minitab statistical software packthe end of each phase.
age (Minitab Inc, State College, PA, USA) was used to explore the relationship of orthostatic BP to changes in PRA, sodium excretion and 24-h SBP.
Sample analysis
Total cholesterol and triglycerides were analysed on Results a Hitachi 717EB analyser (Lewes, East Sussex, UK) using a colorimetric method (CHOD-PAP and GPOAll 17 subjects completed the study with no adverse PAP, respectively). High density lipoprotein-choleseffects reported and in particular no complaints of terol (HDL-C) was measured in the supernatant folpostural symptoms. Baseline characteristics of the lowing phosphotungsten-magnesium precipitation subjects are shown in Table 1 . and centrifugation, and low density lipoproteincholesterol (LDL-C) was then calculated from Fried- × 100/serum creatinine.
Sixteen subjects underwent satisfactory 24-h BP phate, alkaline phosphatase, PTH and glucose were similar between phases of the study. monitoring (defined as Ͼ85% complete records) at completion of the high and low sodium phases. There was a difference in sodium excretion of Lipids: Total HDL-C, and LDL-C and triglycerides were similar at completion of the high and low 95 mmol/24-h between low and high sodium intake periods. Clinic supine SBP was 8 mm Hg (95% CI: sodium phases of the study. No significant correlation between changes in any lipid subfraction and 1-15 mm Hg, P Ͻ 0.05) lower on the low compared to high sodium intake although the fall in supine changes in sodium excretion, PRA and 24-h SBP were found. Also on dividing subjects into DBP was not significant (1 mm Hg; CI −3 to ϩ5 mm Hg). The change in mean 24-h SBP and DBP 'responders' and 'non-responders' to sodium restriction, no significant difference in lipid subfractions from the high to low sodium phase was inversely correlated with the rise in PRA (r = −0.61, P = 0.01; was seen. and r = −0.53, P = 0.03; respectively), ie, there was a greater reduction in 24-h SBP and DBP in those
Renal function: Serum electrolytes, urea, creatinine, creatinine clearance and urinary albumin subjects with an attenuated rise in PRA whilst on the low sodium intake. Differences in PRA, aldosexcretion rate were similar on low and high sodium intakes in all subjects and in 'responders' and 'nonterone and other variables between 'responders' and 'non-responders' are shown in Table 2 .
responders' to sodium restriction. There was a significantly greater serum urate concentration on the low compared to high sodium intake.
Orthostatic BP changes
Supine, standing and orthostatic changes in BP and Discussion pulse rate with the levels of sodium excretion during each phase of the study are shown in Table 3 .
In healthy, elderly, hypertensive subjects a reduction in sodium intake of 80 mmols/24-h for 5 Orthostatic BP changes were similar whether measured at 1, 2 or 3 min of standing, the mean of these weeks to levels of 95 mmols/24-h, a level recommended for the population, produced no adverse measurements was therefore used. Although mean orthostatic falls were seen in SBP and rises in DBP effects on orthostatic BP tolerance, serum lipids, glucose, or renal function as assessed by serum electroand pulse rate, there was no significant difference in these orthostatic changes between periods of the lytes, urea, creatinine, creatinine clearance or urinary albumin excretion. In addition, when subjects study on the varying levels of sodium excretion, in particular between the 5 weeks of high and low were divided into 'responders' to a low sodium intake, arbitrarily defined by a reduction in mean sodium intake.
On defining 'salt-sensitivity' on the basis of 24-h SBP of у5 mm Hg from that on the high sodium intake, no difference in these parameters between changes in ambulatory SBP between low and high sodium phases, and treating this as a continuous responders and non-responders was seen. However, whether such a distinction between 'responders' variable, there was no correlation between 'salt-sensitivity' and orthostatic hypotension during either and 'non-responders' to sodium restriction is valid at all remains questionable. 29 Whether a longer perphase of the study. On multiple linear regression analysis there was no significant association of the iod on a low sodium diet or more severe sodium restriction would result in significant changes to the orthostatic BP change on either phase of the study with PRA, change in PRA between phases, the level above variables cannot be answered by this study. Although the study group size was small, it had the of, or change in sodium excretion or mean 24-h SBP between study phases.
power to reveal clinically important differences in orthostatic BP and lipid changes between high and low sodium phases. Indeed significant changes in Metabolic changes: Results of metabolic parameters at completion of the high and low sodium metabolic variables have been recorded although with greater degrees of sodium restriction in similar phases are shown in Table 4 . Serum calcium, phos- Orthostatic change SBP (mm Hg) 11 ± 15 † 10 ± 13 † 7 ± 15 10 ± 13* 3 ± 17 9 ± 15* 6 ± 14 DBP (mm Hg) −4 ± 8* −4 ± 6* −5 ± 8* −3 ± 7 −3 ± 9 −3 ± 6 −7 ± 10* PR (beats/min) −10 ± 11 † −7 ± 12* −6 ± 9 † −10 ± 7 † −9 ± 8 † −8 ± 9 † −6 ± 7 † Mean 24-h urine excretion Na (mmol/24-h) 164 ± 40 104 ± 59 95 ± 36 174 ± 40 Na:Cr 22 ± 8 1 3 ± 7 1 2 ± 4 2 3 ± 8 K (mmol/24-h) 67 ± 24 66 ± 25 65 ± 18 68 ± 24 K : Cr 8.7 ± 3.2 8.0 ± 2.9 8.3 ± 2.3 8.8 ± 3.4 volume (ml) 1775 ± 420 1773 ± 498 1779 ± 376 1768 ± 415 *P Ͻ 0.05, †P Ͻ0.01 within group change. Supine, standing and orthostatic changes in mean (± s.d.) BP and pulse rate with levels of 24-h urinary sodium (Na) and potassium (K) excretion urine volume and the urinary sodium : creatinine (Na : Cr) and potassium : creatinine (K : Cr) ratio for all 17 subjects during each period of the study. has been recommended that sodium chloride be PTH (pmol/L) 3.7 ± 1.6 3.9 ± 1.7 used as a treatment for vasodepressor syncope. 35 Glucose (mmol/l) 5.9 ± 0.7 6.0 ± 0.8
The prevalence of orthostatic hypotension is the prevalence or severity of orthostatic hypotension
Creatinine clearance (ml/min) 97 ± 31 95 ± 32 would clearly be undesirable. Subjects in the present study were well and untreated with antihy-*P = Ͻ0.05.
pertensive drugs with no evidence of, or predisChanges in blood lipids, blood chemistry, urinary albumin excretion and creatinine clearance in the 17 study subjects at position to, orthostatic hypotension other than being completion of the 5-week low and high sodium periods.
elderly and mildly hypertensive. There was no evidence in these persons of a greater orthostatic BP fall on a low compared to high sodium intake. Furor smaller group sizes compared to the present thermore there was no association of PRA with the study. 24, 30, 31 orthostatic BP changes, and no evidence that orthoSeveral investigators have reported on adverse cirstatic responses differed between 'salt-resistant' subculatory and metabolic effects occurring with jects showing attenuation of PRA to the low sodium sodium restriction. [16] [17] [18] [19] [21] [22] [23] [24] However, these studies intake and 'salt-resistant' subjects where renin usually involve severe sodium restriction often to activity was twice as great. Stimulation of renin below 20 mmol/24-h for short periods, usually 1-3 release on upright posture occurs in young subjects weeks. As noted by others it is doubtful whether the and may be of importance in maintaining standing results of such studies have any relevance to the BP. 41 However in elderly persons such responses effects of long-term moderate sodium restriction of may be of less importance in BP homeostasis on 80-100 mmol/24-h. 32, 33 Unfortunately there have been no long-term studies assessing the risks and standing. Both Kenny et al 42 and Lye et al 43 found no difference in the PRA response to upright tilt in In summary, short-term moderate sodium restriction to 90-100 mmols/24-h in well elderly subjects elderly persons with or without head up tiltinduced hypotension. It is possible that in the frail produced no adverse metabolic or haemodynamic effects other than a modest increase in serum uric elderly, those prone to dehydration by for example concomitant diuretic use, or taking antihypertensive acid. therapy, and those with a pre-existing tendency to orthostatic hypotension, a moderate degree of (Ͻ50 mmols/24-h) sodium restriction by some [21] [22] [23] [24] Fall in blood pressure with modest reduction in dietbut not all investigators 45 in younger subjects. Such ary salt intake in mild hypertension. initial increase in total and LDL-C to be less pro- sodium excretion to moderately low levels for 5
References
5 Joint National Committee on Detection, Evaluation and weeks had no effect on total, LDL-C, HDL-C or trigly- majority were black, in this study all were white, a 417-425. factor that may be of relevance. 52 The increase in tubular reabsorption.
